Effect of durable hematocrit control and minimal thrombotic risk in real-world polycythemia vera patients treated with ruxolitinib
Aleksander Lech Chojecki,Danielle Boselli, Allison Dortilus,Issam Hamadeh, Stephanie Begley,Tommy Chen,Rupali Bose,Nikolai Alexandrovich Podoltsev,Amer Methqal Zeidan, Nicole Baranda Balmaceda,Abdulraheem Yacoub,Jing Ai,Thomas Gregory Knight,Brittany K. Ragon,Nilay Arvind Shah, Srinivasa Sanikommu,James Thomas Symanowski,Ruben A. Mesa,Michael Richard Grunwald JOURNAL OF CLINICAL ONCOLOGY（2023）
关键词
durable hematocrit control,ruxolitinib,minimal thrombotic risk,real-world
AI 理解论文
溯源树
样例
